Clinical Trials Directory

Trials / Terminated

TerminatedNCT02475525

Oral Nutritional Supplement in Reducing Surgical Site Infections

The Role of an Arginine Enriched Oral Nutritional Supplement in the Prevention of Wound Complication in Patients Undergoing Lower Limb Revascularization

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
University of Limerick · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the efficacy of an arginine enriched oral nutritional supplement in the prevention of wound complications in the the wounds of patients post lower limb revascularization.

Detailed description

Surgical incisions are associated with a number of possible complications. The reported incidence of surgical site infections at the groin after vascular procedures is between 3% and 30%. This incidence is up to five times higher than the expected incidence of infection in clean cases. Risk factors for postoperative surgical site infection in patients undergoing vascular surgery may include age, co-morbidities, use of prosthetic grafts and repeat operations. A systematic review in 2011 concluded that arginine supplemented diets among perioperative patients were associated with a reduced rate of surgical infection and reduced overall length of hospital stay. The study aims are to determine if taking an oral nutritional supplement reduces the rate of wound complications post lower limb revascularization.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTArginine enriched oral nutritional supplementoral nutritional supplement containing arginine

Timeline

Start date
2015-06-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2015-06-18
Last updated
2018-05-04

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT02475525. Inclusion in this directory is not an endorsement.